P3 Health Partners Inc (PIII)
0.55
+0.08
(+17.45%)
USD |
NASDAQ |
Apr 30, 16:00
0.55
0.00 (0.00%)
After-Hours: 20:00
P3 Health Partners Cash from Financing (TTM): 100.33M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 100.33M |
| September 30, 2023 | 116.17M |
| June 30, 2023 | 115.08M |
| March 31, 2023 | 26.68M |
| Date | Value |
|---|---|
| December 31, 2022 | 11.38M |
| September 30, 2022 | -3.648M |
| June 30, 2022 | 10.07M |
| March 31, 2022 | 11.28M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.648M
Minimum
Sep 2022
116.17M
Maximum
Sep 2023
48.42M
Average
19.03M
Median
Cash from Financing (TTM) Benchmarks
| American Shared Hospital Services | 1.91M |
| Novo Integrated Sciences Inc | 4.668M |
| Astrana Health Inc | 3.421M |
| Cryo-Cell International Inc | -0.7611M |
| Biote Corp | -14.38M |